Literature DB >> 3088958

The controversy over transdermal nitroglycerin: an update.

B Charash, S S Scheidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3088958     DOI： 10.1016/0002-8703(86)90708-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

1.  The effect of transdermal nitroglycerin on exercise tolerance in relation to patch application time--a meta-analysis.

Authors:  T O Klemsdal; K Gjesdal
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

2.  Tolerance to glyceryl trinitrate patches: prevention by intermittent dosing.

Authors:  C Cowan; J Bourke; D S Reid; D G Julian
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-28

Review 3.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Various administration forms of nitrates and their possibilities.

Authors:  U E Jonsson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

Authors:  P A Todd; K L Goa; H D Langtry
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

6.  Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.

Authors:  K M Fox; H J Dargie; J Deanfield; A Maseri
Journal:  Br Heart J       Date:  1991-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.